Edward A. Stadtmauer

faculty photo
Professor of Medicine at the Hospital of the University of Pennsylvania
Co-Leader, Hematologic Malignancies Program, University of Pennsylvania Abramson Cancer Center
Co-Leader, Hematologic Malignancies Translational Center of Excellence, Penn Medicine/Abramson Cancer Center
Chief, Section of Hematologic Malignancies, Division of Hematology-Oncology, Department of Medicine
Department: Medicine

Contact information
2 Perelman Center for Advanced Medicine
34th and Civic Center Bld
2-319S
Philadelphia, PA 19104
Office: 2156627910
Fax: 215-662-4064
Education:
A.B. (Biochemistry)
Cornell University, College of Arts and Sciences, 1979.
M.D. (Medicine)
University of Pennsylvania School of Medicine, 1983.
Permanent link
 

Description of Research Expertise

Clinical trials, Bone Marrow Transplant

Description of Itmat Expertise

Dr. Stadtmauer is pursuing new treatment approaches to improve the long term survival of patients with leukemia, lymphoma, myeloma and those undergoing bone marrow transplant.

Selected Publications

Garfall, Alfred L; Stadtmauer, Edward A; June, Carl H.: Chimeric Antigen Receptor T Cells in Myeloma. New England Journal of Medicine 374(2): 194, Jan 14 2016.

Shah JJ, Stadtmauer EA, Abonour R, Cohen AD, Bensinger WI, Gasparetto C, Kaufman JL, Lentzsch S, Vogl DT, Gomes CL, Pascucci N, Smith DD, Orlowski RZ, Durie BG.: Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma. Blood 126(20): 2284-90, Nov 12 2015.

Garfall, Alfred L; Maus, Marcela V; Hwang, Wei-Ting; Lacey, Simon F; Mahnke, Yolanda D; Melenhorst, J Joseph; Zheng, Zhaohui; Vogl, Dan T; Cohen, Adam D; Weiss, Brendan M; Dengel, Karen; Kerr, Naseem D S; Bagg, Adam; Levine, Bruce L; June, Carl H; Stadtmauer, Edward A.: Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma. New England Journal of Medicine 373(11): 1040-7, Sep 10 2015.

Rapoport, Aaron P; Stadtmauer, Edward A; Binder-Scholl, Gwendolyn K; Goloubeva, Olga; Vogl, Dan T; Lacey, Simon F; Badros, Ashraf Z; Garfall, Alfred; Weiss, Brendan; Finklestein, Jeffrey; Kulikovskaya, Irina; Sinha, Sanjoy K; Kronsberg, Shari; Gupta, Minnal; Bond, Sarah; Melchiori, Luca; Brewer, Joanna E; Bennett, Alan D; Gerry, Andrew B; Pumphrey, Nicholas J; Williams, Daniel; Tayton-Martin, Helen K; Ribeiro, Lilliam; Holdich, Tom; Yanovich, Saul; Hardy, Nancy; Yared, Jean; Kerr, Naseem; Philip, Sunita; Westphal, Sandra; Siegel, Don L; Levine, Bruce L; Jakobsen, Bent K; Kalos, Michael; June, Carl H.: NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma. Nature Medicine 21(8): 914-21, Aug 2015.

Reshef, Ran; Huffman, Austin P; Gao, Amy; Luskin, Marlise R; Frey, Noelle V; Gill, Saar I; Hexner, Elizabeth O; Kambayashi, Taku; Loren, Alison W; Luger, Selina M; Mangan, James K; Nasta, Sunita D; Richman, Lee P; Sell, Mary; Stadtmauer, Edward A; Vonderheide, Robert H; Mick, Rosemarie; Porter, David L.: High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity Conditioning. Journal of Clinical Oncology 33(21): 2392-8, Jul 20 2015.

Bagley, Stephen J; Sehgal, Alison R; Gill, Saar; Frey, Noelle V; Hexner, Elizabeth O; Loren, Alison W; Mangan, James K; Porter, David L; Stadtmauer, Edward A; Reshef, Ran; Luger, Selina M.: Acute cholecystitis is a common complication after allogeneic stem cell transplantation and is associated with the use of total parenteral nutrition. Biology of Blood & Marrow Transplantation 21(4): 768-71, Apr 2015.

Waxman, A J; Mick, R; Garfall, A L; Cohen, A; Vogl, D T; Stadtmauer, E A; Weiss, B M.: Classifying ultra-high risk smoldering myeloma. Leukemia 29(3): 751-3, Mar 2015.

Frosch, Zachary; Luskin, Marlise R; Landsburg, Daniel J; Schuster, Stephen J; Svoboda, Jakub; Loren, Alison W; Porter, David L; Stadtmauer, Edward A; Nasta, Sunita D.: R-CHOP or R-HyperCVAD with or without autologous stem cell transplantation for older patients with mantle cell lymphoma. Clinical lymphoma, myeloma & leukemia 15(2): 92-7, Feb 2015.

Appelbaum, Frederick R; Anasetti, Claudio; Antin, Joseph H; Atkins, Harold; Davies, Stella; Devine, Steven; Giralt, Sergio; Heslop, Helen; Laport, Ginna; Lee, Stephanie J; Logan, Brent; Pasquini, Marcelo; Pulsipher, Michael; Stadtmauer, Edward; Wingard, John R; Horowitz, Mary M.: Blood and marrow transplant clinical trials network state of the Science Symposium 2014. Biology of Blood & Marrow Transplantation 21(2): 202-24, Feb 2015.

Freytes, Cesar O; Toro, Juan J; Yeh, Rosa F; Stadtmauer, Edward A; Ratanatharathorn, Voravit; Akpek, Gorgun; Sahovic, Entezam; Tricot, Guido J; Shaughnessy, Paul J; White, Darrell J; Rodriguez, Tulio E; Solomon, Scott R; Yu, Louie H; Zhao, Cathy; Patil, Shiva; Armstrong, Elizabeth; Smith, Angela; Elekes, Agnes; Kato, Kazunobu; Reece, Donna E.: Safety and efficacy of targeted-dose busulfan and bortezomib as a conditioning regimen for patients with relapsed multiple myeloma undergoing a second autologous blood progenitor cell transplantation. Biology of Blood & Marrow Transplantation 20(12): 1949-57, Dec 2014.

back to top
Last updated: 02/11/2016
The Trustees of the University of Pennsylvania